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We have deployed recombinant adeno-associated viruses equipped with tetracycline-
controlled genetic switches to manipulate gene expression in mouse brain. Here, we
show a combinatorial genetic approach for inducible, cell type-specific gene expression
and Cre/loxP mediated gene recombination in different brain regions. Our chemical-
genetic approach will help to investigate ‘when’, ‘where’, and ‘how’ gene(s) control
neuronal circuit dynamics, and organize, for example, sensory signal processing,
learning and memory, and behavior.
Keywords: tetracycline inducible systems, Cre mediated recombination, rAAVs, brain circuits, learning and
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Introduction
Brain is a complex organ, with highly organized genetic and cellular programs that engages neural
circuits to generate synaptic speciﬁcity (Yogev and Shen, 2014) and plasticity (Citri and Malenka,
2008; Huganir and Nicoll, 2013), controlling a diverse range of biological functions, for example,
sensory signal detection, movement, decision-making, and learning and memory (Tonegawa et al.,
2003; Kandel et al., 2014).
An attractive hypothesis is that local and distributed neural circuits encode biological functions.
To test this hypothesis, it is imperative to ‘causally’ link the anatomical and functional organi-
zation of the neural circuits to biological functions. Manipulating circuit dynamics (Deisseroth,
2014) is paving the way to understand the operating principles of normal and aberrant brain states.
Within this framework, understanding the role of gene function(s) in circuit dynamics and biolog-
ical functions is an important ﬁrst step in determining the rules and mechanisms that orchestrate
changes across diﬀerent synaptic connections throughout the brain. The application of inducible
gene expression systems to manipulate various genes, the building blocks of circuit function(s), in
identiﬁed brain regions and cell types will help to reveal the molecular and cellular mechanisms
that control and regulate biological functions.
The tetracycline (tet) inducible systems (Sprengel and Hasan, 2007) are adequately suitable for
investigating various biological processes in the brain. The tet systems have three key components:
(1) The transactivator (tTA; Gossen and Bujard, 1992) or the reverse tTA (rtTA; Urlinger et al.,
2000), which are artiﬁcially designed potent transcription factors that can be expressed constitu-
tively in cells under control of a ubiquitous or a cell type speciﬁc promoter. (2) A tet responsive
minimal promoter (either unidirectional Ptet or bidirectional Ptetbi; Baron et al., 1995; Sprengel and
Hasan, 2007), which become strongly activated upon binding to tTA/rtTA. (3) A chemical inducer,
doxycycline (Dox; Bocker et al., 1981), that can rapidly cross the blood–brain-barrier (Bocker
et al., 1981), and controls the binding of tTA/rtTA to Ptet/Ptetbi. The tTA and rtTA, commonly
called Tet-oﬀ and Tet-on, respectively, are complementary systems (Sprengel and Hasan, 2007).
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Without Dox, tTA binds to Ptet/Ptetbi to activate gene expres-
sion. However, when Dox binds to tTA, a conformational change
in tTA disables its ability to bind Ptet/Ptetbi, inactivating gene
expression. The reverse is the case for rtTA; only the Dox-rtTA
complex can bind to Ptet/Ptetbi to activate gene expression, which
becomes inactivated when Dox unbinds rtTA.
In particular, the tTA system has been used in transgenic
rodents to repetitively turn ‘on’ and ‘oﬀ ’ gene expression by Dox
withdrawal and addition, respectively, (Hasan et al., 2001). The
tet systems also allow for gene expression-ampliﬁcation (Hasan
et al., 2004). For inducible gene fragment deletion by Cre/loxP
mediated recombination, the tTA system is, however, quite cum-
bersome. In transgenic tTAmousemodels, for Cre/loxPmediated
gene manipulation, Cre gene expression in unborn transgenic
animals is switched-oﬀ by treating pregnant females with Dox. In
addition, before investigating speciﬁc biological processes, gene
expression in newborn pups, is also switched-oﬀ by Dox. During
both prenatal and pup rearing stages, the Dox reaches the unborn
and newly born animals via placenta andmilk, respectively. There
are two problems with such an approach: (1) Dox availability to
the brain via milk is not eﬃcient, which increases the likelihood
for undesired Cre/loxP mediated recombination and (2) Dox
provided via the placenta in embryos, before blood–brain-barrier
is formed, strongly suppresses Cre gene expression, which tend
to silence Ptet/Ptetbi, disabling gene activation by Dox withdrawal
at later stages (Zhu et al., 2007). With excessive accumulation of
Dox in tissues during prenatal development, and slow time course
of Dox clearance, it can take several months before Cre gene
expression can be switched-on by Dox removal. Even after Dox
clearance, Cre gene expression in a majority of neurons remains
switched-oﬀ (Zhu et al., 2007). However, the rtTA system pro-
vides a potential solution to this setback. With the rtTA system,
Dox activates gene expression via Ptet/Ptetbi (Zhu et al., 2007).
Although the rtTA system works well in various body tissues, its
performance is ineﬃcient in the brain of transgenic mammals
(Zhu et al., 2007).
In our previous study, we systematically investigated this
problem and showed that when tet promoters (Ptet/Ptetbi) are
switched-oﬀ during development, they becomes epigenetically
silenced in neurons (Zhu et al., 2007). However, introducing a
Ptetbi module in recombinant adeno-associated viruses (rAAVs),
which remain largely episomal (Schnepp et al., 2005) in cells, epi-
genetic silencing of Ptetbi in neurons can be avoided (Zhu et al.,
2007). Taking advantage of this discovery, we developed AAVs
for reliable and eﬃcient inducible gene expression in brain (Zhu
et al., 2007). Our approach is based on two diﬀerent viruses,
which can be delivered in the brain by stereotactic injection
(Zhu et al., 2007; Wallace et al., 2008). The ﬁrst virus deliv-
ers in neurons the rtTA (rtTA2-nM2; Zhu et al., 2007) gene
under a pan-neuronal human synapsin promoter (Zhu et al.,
2007; Cambridge et al., 2009; Hasan et al., 2013). The second
virus delivers Ptetbi to simultaneously express two diﬀerent genes
(tdTomato and iCre; Cambridge et al., 2009; Hasan et al., 2013) in
a Dox-controlled, rtTA dependent manner. The AAVs oﬀer other
key advantages as well; they allow for precise and combinatorial
targeting of brain region(s) at diﬀerent stage over the course of
biological studies, something that is currently not possible with
traditional transgenic animal models. The availability of diﬀer-
ent AAV serotypes and synthetic capsid proteins is expanding the
versatility of the AAV-based approach by targeting diverse cell
types (Wang et al., 2011; Drouin and Agbandje-McKenna, 2013),
with limited or no immune response (Drouin and Agbandje-
McKenna, 2013). Therefore, AAVs have great potentials for
investigating basic brain functions and are ideally suited as gene
therapy vectors to treat neurological diseases (Bourdenx et al.,
2014).
In this study, we deployed AAVs for Dox-controlled, rtTA-
dependent expression of two genes, Cre (Shimshek et al., 2002)
and tdTomato (tdTOM; Shaner et al., 2005). The Cre recombi-
nase allows for Cre/loxP mediated gene manipulation (Capecchi,
2005) of diﬀerent brain regions and tdTOM marks the cells for
live imaging. Our experimental approach will facilitate investiga-
tion of gene function(s) in diverse biological processes, including
learning and memory (Hasan et al., 2013).
Materials and Methods
Mice
C57BL/6N (Charles River, Sulzfeld, Germany) and gene-targeted
Gt(ROSA)26Sortm1Sor/J mice were housed under standard condi-
tions in a 12 h light/dark cycle in Makrolon cage type-2A with
food and water. All animal procedures were performed with
permission and in accordance with German governmental reg-
ulation on animal experimentation (Regional Council Karlsruhe,
Germany: 35-9185.81/G171/10).
Plasmid Constructs
The plasmids pAAV-hSYN-rtTA2-nM2 (Zhu et al., 2007; Hasan
et al., 2013) and pAAV-Ptetbi-iCre/tdTOM (Cambridge et al.,
2009; Hasan et al., 2013) used here have been described previ-
ously. The GenBank Accession Numbers for these plasmids are
KP893810 and KP893811, respectively.
Virus Purification
Serotypes 1 and 2 rAAVs were generated by transfection
into HEK293 cells and puriﬁed as described previously (Zhu
et al., 2007). In brief, each AAV plasmid, pAAV-hSYN-rtTA2-
nM2 (Zhu et al., 2007; Hasan et al., 2013) and pAAV-Ptetbi-
iCre/tdTOM (Cambridge et al., 2009; Hasan et al., 2013) was
individually co-transfected with pDp1 (for serotype 1) and pDp2
(for serotype 2) helper plasmids at a ratio of 2:1:1 per 15-cm
plate (25 mg pAAV, 12.5 mg pDp1 and 12.5 mg pDp2) into
HEK293 cells by the DNA/Ca2+PO4 mediated co-precipitation
(Chen and Okayama, 1987). We plated HEK cells on twenty 15-
cm plates with 25 ml of DMEM medium per plate. On the day
of transfection, the cells should be 50% conﬂuent. Forty-eight
hours after transfection (50% eﬃciency), cells were harvested
and collected in 50 ml tubes and pelleted by centrifugation at
2000 rpm for 5 min. The cell pellets were suspended in 45 ml
of suspension buﬀer (150 mM NaCl, 20 mM Tris.HCl, pH 8.0)
and 0.5 ml of 10% sodium deoxycholate (NaDOC) was added
(ﬁnal concentration of 0.5% NaDOC). To the well-mixed cell
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lysate was added benzonase (40 U/ml), mixed well, and incu-
bated at 37C◦ for 60 min. At this stage, cell lysates were frozen
at −70◦C. Before puriﬁcation, cell lysates were thawed at room
temperature and centrifuged at 4000 rpm for 15 min, super-
natant collected in a new 50-ml tube and frozen again at −70◦C
overnight. The next day, supernatant was thawed and centrifuged
at 4000 rpm for 15 min. A clear supernatant was passed through
a pre-equilibrated 1-ml heparin column (Amersham, Freiburg,
Germany) using a pump device. The column was serially washed
with 20 ml of 100 mM NaCl, 20 mM Tris.HCl (pH 8), 1 ml of
200 mM NaCl, 20 mM Tris.HCl (pH 8), and 1 ml of 300 mM
NaCl, 20 mM Tris.HCl (pH 8). The virus was eluted with 1.5 ml
of 400 mM NaCl, 20 mM Tris.HCl (pH 8), 3 ml of 450 mM
NaCl, 20 mM Tris.HCl (pH 8), and 1.5ml of 500 mM NaCl,
20 mM Tris.HCl (pH 8). The eluted virus was pooled into a 15-
ml Amicon Ultra concentrator (Millipore) and ﬁlled to the top
with 1x PBS. After centrifugation at 2000 rpm for 10 min, the
ﬂow through was discarded, and the reservoir was re-ﬁlled with
1x PBS. This procedure was repeated a total of three times. The
concentrated viruses (200 µl) were sterilized through a 0.2 µm
small size ﬁlter device, aliquoted into eppendorf tubes, and stored
at -80◦C until use. A small sample of puriﬁed virus (10 ml) was
analyzed by SDS-PAGE. The gel was stained for 45 min with
Coomassie blue and destained for another 45 min, and washed
5x with water, until protein bands were clearly visible. With suc-
cessful virus puriﬁcation, three bands corresponding to the viral
capsid proteins can be seen, with expected molecular weights of
87 kDa (VP1), 73 kDa (VP2), and 62 kDa (VP3).
Responder Virus with Minimal Leakiness
To reduce leakiness of the Ptetbi responder virus (rAAV-Ptetbi-
iCre/tdTOM; Cambridge et al., 2009; Hasan et al., 2013), highly
concentrated virus were titered [genomic titer of 1–3 × 1013
vector genome (vg) per milliliter]. The responder virus (rAAV-
Ptetbi-iCre/tdTOM) was diluted 1:1, 3:1, 10:1, and 30:1 with
respect to the activator virus (rAAV-hSYM-rtTA2-nM2; Zhu
et al., 2007; Hasan et al., 2013). About 500 nl of virus cock-
tail, rAAVPtetbi-iCre/tdTOM, and rAAV-hSYN-rtTA2-nM2, was
added directly and gently on top of hippocampus organotypic
brain slices. Medium was changed after 5 days and, subsequently,
every 3 days. Two weeks after virus infection, two slices were
incubated with 1 µg/ml Dox in the medium for 48 h and two
slices were kept without Dox (control). Forty-eight hours after
Dox addition, tissues were washed in warm 1x PBS and ﬁxed in
4% PFA. Fixed tissues were imaged for tdTOM expression. The
diluted virus cocktail that showed undetectable tdTOM expres-
sion (without Dox) and strong tdTOM expression with Dox was
chosen for in vivo application.
Stereotactic Virus Injection in Mouse Brain
C57BL/6N and Gt(ROSA)26Sortm1Sor/J mice were deeply anes-
thetized with ketamine (100 mg/kg) and xylazine (5 mg/kg),
and were secured in a Kopf stereotaxic setup (Kopf Instruments,
Tujunga, CA, USA). The foreskin on the skull was cut open to
expose the skull. A small hole (50–100µm)wasmade through the
skull using a dental drill. A glass pipette delivered approximately
200 nl of virus cocktail by injection into diﬀerent brain regions;
cortex and hippocampus. The coordinates used for the injec-
tions are with reference to the bregma: cortex (–1.70 mm bregma,
1.5 mm lateral, 500 µm deep) and hippocampus (–1.70 mm
bregma, 1.5 mm lateral, 1.5 mm deep). After virus injection, the
skin was sutured and the wound was disinfected. Virus injected
mice were kept on a heating blanket at 37◦C until they woke up,
and were fed wet food during recovery.
Dox Treatment In Vivo
For intraperitoneal injection, stock Dox solution (5 mg/ml in
0.9%NaCl) was prepared. Eﬀective dose is 50µg of Dox per gram
body weight (10 µl of Dox per 1 g of animal weight).
Fixed Brain Slices
Mice were anesthetized by isoﬂurane inhalation followed by
intracardial perfusion with PBS and 4% paraformaldehyde (PFA).
Brains were removed and post-ﬁxed in 4% PFA for 2 h at 4◦C,
kept in 1x PBS at 4◦C overnight, washed 3x with PBS and
embedded in 2.5% agarose (in 1x PBS). Typically, we prepared
vibratome (VT1000S, Leica, Wetzlar, Germany) brain slices,
which were 60–100 µm in thickness. Coronal brain slices were
stored in 1x PBS at 4◦C.
Immunohistochemistry
Brain slices were incubated in 4% normal goat serum (sup-
plemented with 1% BSA, 0.3% TritonX-100) for 15 min and
then incubated overnight at room temperature with primary
Cre-antibody (mouse monoclonal anti-Cre; 1:1000, Covance,
Germany) diluted in PBS/ 1% BSA/ 1% normal goat serum/
0.3% TritonX-100. The next day, brain slices were washed 2x in
1x PBS/ 0.3% BSA/ 0.1% TritonX-100 (D2), followed by incuba-
tion with anti-mouse FITC secondary antibody (1:200, Jackson
Immuno Research) for 1 h at room temperature. Brain slices
were washed in 1x D2 buﬀer followed by a single wash in 1x
PBS and mounted with Aqua Poly/Mount on glass slides with
coverslips.
β-Galactosidase Assay
rAAV-hSYN-rtTA2-nM2 (Zhu et al., 2007; Hasan et al., 2013)
and rAAV-Ptetbi-iCre/tdTOM (Cambridge et al., 2009; Hasan
et al., 2013) were co-injected into the hippocampus and cortex
of Gt(ROSA)26Sortm1Sor/J mice. Two weeks after virus injection,
mice were either not treated or treated with Dox by a single
intraperitoneal injection. After 48 h, animals were sacriﬁced,
brains were ﬁxed and sliced as described above. To visualize β-
galactosidase activity, ﬁxed brain slices were incubated in X-gal
solution (5 mM K4Fe(CN)6, 5 mM K3Fe(CN)6, 2 mM MgCl2,
2 mg/ml X-Gal in dimethylformamide/PBS) at room tempera-
ture for 30–60 min. Sections were washed 3x in PBS, 1x in 10 mM
Tris-HCl pH 7.5 and, subsequently, mounted on glass slides with
Aqua Poly/Mount (Polysciences, Inc., Warrington, PA, USA) and
protected with cover slips and later imaged.
Imaging
Light and ﬂuorescence imaging were performed with Zeiss
Axioplan-2 (Carl Zeiss, Jena, Germany) with the camera system
AxioCam HRC with magniﬁcations ranging from 2.5× to 40×
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dry or 63× oil immersion objectives (software: Axiovision 4.8.1)
and a compact light source (Leistungselectronic Jena, Germany)
with 488 nm and 568 nm ﬁlters. Confocal images were acquired
with Zeiss LSM PASCAL confocal laser-scanning microscope
equipped with an Argon laser (457, 476, 488, and 514 nm) and
a Helium Neon laser (543 nm) with objectives 5×–40× dry and
63× oil-immersion objective. Images were analyzed with ImageJ
and LSM image browser.
Results
Gene Activation with Tet Promoters
To achieve Tet-inducible gene expression and gene deletion in
mouse brain, we used two rAAVs, rAAV-hSYN-rtTA2-nM2 (Zhu
et al., 2007; Hasan et al., 2013) and rAAV-Ptetbi-iCre/tdTOM
(Zhu et al., 2007; Cambridge et al., 2009; Hasan et al., 2013), and
loxP-STOP-loxP-lacZ reporter (Gt(ROSA)26Sortm1Sor/J ; Soriano,
1999) transgenic mice (Figures 1A,B). The ﬁrst virus (rAAV-
hSYN-rtTA2-nM2) is equipped with the human synapsin pro-
moter to drive rtTA (rtTA2-nM2) expression. The second virus
(rAAV-Ptetbi-iCre/tdTOM) has a bidirectional tet promoter
(Ptetbi) to express two responder genes, iCre (Shimshek et al.,
2002) and tdTomato (Shaner et al., 2005; tdTOM; Figure 1A).
These two viruses were injected in the cortex of four wild-type
mice. Two weeks later, twomice were treated with Dox by a single
intraperitoneal injection and the other two mice were not treated
with Dox. We found that there was robust expression of tdTOM
and Cre recombinase 2 days after Dox treatment. In the cortex,
expression was largely restricted to neurons of layer 2/3 and 5,
which was evenly distributed in soma and dendrites, but there
was little or no expression in cortical layers 4 and 6 neurons. No
tdTOM and Cre expression was detectable in mice without Dox.
The two transgenes (tdTOM and iCre) under a Ptetbi also showed
faithful co-expression (Figure 2A). Interestingly, when one gene
(GFP variant) was placed under control of a Ptetbi (rAAV-Ptetbi-
GFPvariant, called here rAAV-uni-Ptet-GFPvariant), strong gene
expression was observed, even without Dox (Figure 2B), and
was quite comparable to tdTOM expression under a consti-
tutive human synapsin promoter (Figure 2B). We made this
observation with three diﬀerent GFP-linked genes with a simi-
lar rAAV-uni-Ptet-GFPvariants (data not shown). These results
suggest that the placement of two genes ﬂanking a Ptetbi module
allow for Dox-controlled, rtTA-dependent regulated gene expres-
sion, but not when only one gene is placed under a structurally
intact Ptetbi.
Time Course of Gene Activation
To investigate the time course of Dox-controlled, rtTA-
dependent gene activation in vivo, the two viruses (Zhu et al.,
2007; Cambridge et al., 2009; Hasan et al., 2013; rAAV-hSYN-
rtTA2-nM2 and rAAV-Ptetbi-iCre/tdTOM) were co-injected into
the cortex of 10 wild-type mice. Two weeks later, mice were
divided into ﬁve groups (two mice per group). The ﬁrst group
was without Dox (control) and the other four groups were treated
with Dox with a single intraperitoneal injection, and tdTOM
expression was analyzed after 6, 12, 24, and 48 h in ﬁxed brain
slices. While tdTOM expression was not detectable in mice with-
out Dox (Figure 3, left panel), Dox-treated mice showed strong
expression as early as 6 h, and maximum expression was reached
after 24 h (Figure 3).
Inducible Gene Expression and Cre/LoxP
Mediated Gene Recombination
To achieve neuron- and brain region-speciﬁc inducible gene
expression and Cre/loxP mediated gene recombination, viruses
(Zhu et al., 2007; Cambridge et al., 2009; Hasan et al., 2013;
rAAV-hSYN-rtTA2-nM2 and rAAV-Ptetbi-iCre/tdTOM) were
co-injected in two diﬀerent brain regions in three diﬀerent com-
binations; cortex alone, hippocampus alone, and both cortex and
hippocampus (two mice per group). Two weeks after virus injec-
tion, mice were treated with Dox by a single intraperitoneal
injection. Two mice served as controls (without Dox). Two days
after Dox injection, ﬁxed brain slices showed strong tdTOM
FIGURE 1 | Operating principles. (A) Schematics of rAAV-rtTA system; a
virus with a human synapsin promoter for constitutive, pan-neuronal specific
rtTA expression and another virus with a bidirectional tetracycline (tet) promoter
(Ptetbi) driving two different genes (tdTOM and iCre) in opposite directions.
Binding of doxycycline (Dox) to rtTA enables it to bind to Ptetbi, and gene
expression is bidirectionally switched-ON. In the absence of Dox, rtTA is unable
to bind Ptetbi and gene expression is switched-OFF. (B) Schematic of the lacZ
Cre-dependent reporter in Gt(ROSA)26Sortm1Sor/J mice. The ROSA promoter
drives the expression of the lacZ gene, but this expression is blocked by
transcriptional terminator sequences (STOP), which are flanked by loxP sites.
The terminator STOP fragment is removed by Cre/loxP mediated gene deletion
to activate the expression of the lacZ gene.
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FIGURE 2 | Ptetbi assisted inducible gene expression. (A) After Dox
treatment, the Ptetbi-iCre/tdTOM vector enabled robust tdTOM and iCre
co-expression in an rtTA dependent manner (right), but not without Dox
(left). Both tdTOM and iCre expression was colocalized in cortical neurons
(right; merged image). (B) Expression under the control of
Ptetbi-GFP-variant vector alone was similar, both with and without Dox,
and it compared well with tdTOM expression under the human synapsin
promoter.
FIGURE 3 | Time course of gene activation. After Dox treatment, gene activation was detected in vivo as early as 6 h, which reached maximum levels in the
cortex after 24 h.
expression (Figure 4A). In the hippocampus, expression was
widespread in the dentate gyrus granule cells, and the CA1/CA3
pyramidal neurons. No tdTOM expression was detected in mice
without Dox (Figure 4A). To test for Cre/loxP gene recombina-
tion in speciﬁc brain regions in the Gt(ROSA)26Sortm1Sor/J mice,
viruses (rAAV-hSYN-rtTA2-nM2 and rAAV-Ptetbi-iCre/tdTOM)
were co-injected again in three diﬀerent combinations; cortex
alone, hippocampus alone, and both cortex and hippocampus
(two mice per group). Two weeks after virus injection, mice
were injected with a single dose of Dox and two mice were used
as control (without Dox). Forty-eight hours later, ﬁxed brain
slices showed strong β-galactosidase activity by X-gal staining
(Figure 4B), indicating that Cre/loxP mediated gene recombina-
tion occurred eﬃciently in Dox-treated mice. It should be noted,
however, that if the viruses do not reach the entire brain structure,
as in the case of hippocampus alone example, a small region
would remain untargeted (see CA2 region, Figure 4B, lower right
panel). Control mice, without Dox, showed recombination in
only a few cells (Figure 4B, left panel).
Discussion
Here, we report a versatile genetic approach that takes advantage
of two rAAVs for inducible, brain region, and cell type speciﬁc
gene manipulation. Our proof-of-principle approach is currently
based on the tet inducible gene expression system, namely the
rtTA system, for Dox-induced Cre recombinase expression to
induce Cre/loxP mediated gene recombination. The ﬁrst virus
is equipped with a cell type speciﬁc promoter to express rtTA
(rtTA2-nM2; Zhu et al., 2007). The second virus harbors a bidi-
rectional tet promoter (Ptetbi) to co-express two diﬀerent genes
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FIGURE 4 | Inducible, Cre/loxP mediated gene recombination.
(A) With precisely targeted virus injection, induced tdTOM expression
in cortex alone, hippocampus alone and both cortex and hippocampus.
(B) Cre/loxP mediated recombination to activate the lacZ gene in
different singly targeted brain region and in combination of two regions.
Expression of β-galactosidase was assayed by X-gal staining. Very little
recombination was detectable without Dox (left panel). Ctx, cortex; HP,
hippocampus.
in opposite orientations (Baron et al., 1995). The use of a ﬂu-
orescent protein in Ptetbi, for example, tdTOM (Shaner et al.,
2005), helps tomonitor the expression of a second gene in the tar-
geted brain region(s). Inducible activation of gene expression via
a Ptetbi requires an rtTA and an inducer, Dox, which can be deliv-
ered to the animals by an intraperitoneal injection (Zhu et al.,
2007; applied here) and/or in the drinking water (not applied
here). We found that Dox-induced, rtTA-dependent Ptetbi medi-
ated gene expression in targeted neurons can be detected within,
at least, a few hours. Our AAVs are of a hybrid serotype (1/2),
which appear to largely target layer 2/3 and layer 5 neurons, but
not layer 4 and layer 6 neurons. We have not observed retrograde
labeling with the AAV1/2.
We demonstrate the applicability of virus approach for
inducible gene expression and Cre/loxP mediated gene recom-
bination in the brain of lacZ transgenic reporter mice
[Gt(ROSA)26Sortm1Sor/J ; Soriano, 1999]. It is well established that
the lacZ transgenic reporter mice is a reliable model for natural
ﬂoxed genes. Our approach can also be extended to overexpress
wild-type and mutant genes (Eschbach and Danzer, 2014) and
interference RNA (Murphy et al., 2013; Ramachandran et al.,
2013). With stereotactic virus injection, we can achieve long-
term gene expression in either a single or multiple brain regions,
enabling systematic investigation of how diﬀerent brain regions
participate in various biological processes, for example, learning
and memory.
We found that rAAVs equipped with minimal tet promot-
ers (Ptet/Ptetbi) are not without problems. First, Ptet/Ptetbi have
very low levels of intrinsic transcriptional activity, which is one
source of leakiness. In most cases, this is not a major prob-
lem. However, with a high virus titer, rAAV-Ptetbi-iCre/tdTOM
(Zhu et al., 2007; Cambridge et al., 2009; Hasan et al., 2013)
alone (without rtTA and without Dox), for example, can pro-
duce enough Cre recombinase protein in a small number of
neurons, particularly, at the virus injection brain site(s) to allow
for Cre/loxP mediated gene recombination (data not shown). It is
therefore important to serially dilute Ptetbi viruses with a constant
amount of an rtTA (or tTA) virus and only apply an optimal virus
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cocktail (Ptetbi + rtTA) for eﬃcient and reliable Dox-induced,
rtTA-depednent Cre/loxP mediated gene recombination.
The other issue is that the two ﬂanking inverted terminal
repeats (ITRs; Bohenzky et al., 1988) in rAAVs appear to have
a cryptic enhancer activity. We found that when one gene is
placed under a Ptetbi (equivalent to Ptet), it becomes highly active.
We reasoned that this increase in Ptetbi activity was inﬂuenced
by a nearby ITR. It is known that minimal promoters includ-
ing Ptet/Ptetbi can trap enhancers (Stanford et al., 2001). We thus
speculate that an ITR can act in cis to increase the basal activ-
ity of the minimal tet promoter. This phenomenon might also
explain why gene expression modules ﬂanked by ITR sequences
in transgenic zebraﬁsh enabled stable and uniform gene expres-
sion (Hsiao et al., 2001), throughout generations, but not without
ITRs (Hsiao et al., 2001). In our approach, two diﬀerent genes
(iCre and tdTOM) in rAAV-Ptetbi-iCre/tdTOM (Zhu et al., 2007;
Cambridge et al., 2009; Hasan et al., 2013) appear to shield Ptetbi
from ITR enhancer-like activity; adding DNA sequences of more
than 700 bp in between a Ptetbi appears to minimize the inﬂuence
of the two ITRs onto Ptetbi. Clearly, the proposed role of an ITR
as an enhancer should be investigated more systematically. It still
remains an open question, however, if diﬀerent gene fragments
might insulate Ptet from an adjacent ITR to a diﬀerent extent.
Ours is not the ﬁrst example of a two AAV approach for
inducible gene expression. A previous study elegantly used tet
transsilencer (tTS) and rtTA on one virus and a Ptet (unidirec-
tional) on another virus to express GFP in a Dox-controlled,
rtTA-dependent manner (McGee Sanftner et al., 2001). In that
system, in the absence of Dox, the tTS prevents leaky expression
by Ptet, possibly by blocking the ITR enhancer-like activity. With
Dox treatment, tTS come oﬀ, and rtTA binds to Ptet to activate
gene expression. The important question is how much leaki-
ness was actually prevented by tTS, so that Cre/loxP mediated
recombination would only occurs upon Dox treatment.
The major advantage of our two-virus approach is that either
single or multiple brain regions can be targeted for inducible and
cell type speciﬁc gene manipulation by Cre/loxP mediated gene
recombination. The major drawback is that a single virus injec-
tion can only target a small brain region, but it has the capability
to target larger areas by multiple virus injections (Hasan et al.,
2013). The inducible genetic switches in our viruses provide an
added advantage over a single virus approach for constitutive Cre
recombinase expression; with our approach, Cre/loxP mediated
gene recombination can be activated by Dox treatment after a
particular biological process, such as memory formation, without
causing stress to animals by a surgical intervention for virus injec-
tion, thus avoiding potential stress-related eﬀects. Given that tar-
geting selective brain region(s) for gene expression/manipulation
is a major hurdle with the traditional transgenic, our virus-based
approach can be of a great value for neuroscience research and
gene therapy.
Conclusion
In summary, we show here a two-virus approach for inducible
gene expression and Cre/loxP mediated gene recombination in
the mouse nervous system. Our approach makes it possible to
target a single or multiple brain regions, and thus provides the
neuroscience community with an important genetic tool to inves-
tigate how gene activity, at any particular stage, aﬀects circuit
dynamics in various biological functions, including learning and
memory processes. It also has great potentials for therapeutic
applications.
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